Tobias Banaschewski Selected Research

Sleep Initiation and Maintenance Disorders (Insomnia)

12/2021	Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders.
3/2017	Attention-Deficit/Hyperactivity Disorder.
9/2013	A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tobias Banaschewski Research Topics

Disease

112	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2024 - 01/2004
10	Autism Spectrum Disorder 01/2023 - 11/2011
8	Mental Disorders (Mental Disorder) 05/2024 - 01/2016
7	Conduct Disorder (Conduct Disorders) 01/2024 - 03/2003
7	Autistic Disorder (Autism) 01/2023 - 11/2011
5	Alcoholism (Alcohol Abuse) 01/2024 - 06/2015
5	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 03/2016
5	Tic Disorders (Tic Disorder) 07/2018 - 07/2004
4	Substance-Related Disorders (Drug Abuse) 04/2024 - 08/2013
3	Anorexia Nervosa 08/2023 - 02/2005
3	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2021 - 09/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 01/2014
2	Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder) 01/2024 - 01/2022
2	Headache (Headaches) 01/2022 - 09/2013
2	Schizophrenia (Dementia Praecox) 01/2022 - 01/2016
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 09/2015
2	Hypersensitivity (Allergy) 12/2021 - 12/2015
2	Genetic Predisposition to Disease (Genetic Predisposition) 10/2020 - 04/2012
2	Anxiety Disorders (Anxiety Disorder) 01/2015 - 06/2014
2	Tics (Tic) 07/2010 - 07/2006
1	Binge Drinking 01/2024
1	Gender Dysphoria 01/2024
1	Cerebral Cortical Thinning 10/2023
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 01/2023
1	Tobacco Use Disorder (Nicotine Dependence) 01/2023
1	AIDS-Related Complex (ARC) 01/2023
1	Hyperphagia (Overeating) 01/2023
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Disease Progression 01/2022
1	Weight Gain 10/2020

Drug/Important Bio-Agent (IBA)

35	Methylphenidate (Ritalin)FDA LinkGeneric 02/2024 - 01/2004
16	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2022 - 01/2004
15	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2016
13	Lisdexamfetamine Dimesylate FDA Link 01/2020 - 09/2013
7	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2017 - 03/2003
6	Dopamine (Intropin)FDA LinkGeneric 01/2016 - 07/2004
5	Glutamic Acid (Glutamate)FDA Link 01/2023 - 11/2017
4	AmphetaminesIBA 01/2022 - 09/2012
4	Guanfacine (Tenex)FDA LinkGeneric 01/2022 - 10/2017
4	Antipsychotic Agents (Antipsychotics)IBA 07/2018 - 11/2004
4	ProdrugsIBA 12/2014 - 10/2013
3	Clonidine (ST 155)FDA LinkGeneric 01/2022 - 03/2005
3	Bupropion (Wellbutrin)FDA LinkGeneric 01/2022 - 03/2005
3	Amphetamine (Amfetamine)FDA LinkGeneric 07/2020 - 09/2013
3	Apolipoproteins E (ApoE)IBA 01/2017 - 01/2014
3	ApolipoproteinsIBA 01/2017 - 01/2014
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 09/2015 - 06/2014
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 08/2014 - 04/2007
3	Dopamine Receptors (Dopamine Receptor)IBA 08/2014 - 04/2008
3	Serotonin (5 Hydroxytryptamine)IBA 11/2013 - 10/2008
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2023 - 12/2017
2	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2023 - 03/2017
2	ORALIT (ORS)IBA 01/2022 - 01/2017
2	Modafinil (Provigil)FDA Link 01/2022 - 10/2017
2	Genetic Markers (Genetic Marker)IBA 01/2021 - 04/2008
2	Risperidone (Risperdal Consta)FDA LinkGeneric 07/2018 - 11/2004
2	Tiapride HydrochlorideIBA 07/2018 - 07/2004
2	A-factor (Streptomyces)IBA 07/2018 - 01/2018
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2018 - 04/2012
2	Therapeutic UsesIBA 10/2017 - 09/2013
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 08/2011 - 09/2009
2	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 05/2010 - 09/2009
2	3' Untranslated Regions (3' UTR)IBA 04/2008 - 04/2007
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 03/2005 - 01/2004
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2024
1	Progesterone FDA LinkGeneric 01/2024
1	Hormones (Hormone)IBA 01/2024
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2024
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 10/2023
1	Olanzapine (Zyprexa)FDA Link 08/2023
1	gamma-Aminobutyric Acid (GABA)IBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	InterferonsIBA 01/2023
1	carbetocinIBA 01/2023
1	4- (3,4- dichlorophenyl)- 1,2,3,4- tetrahydronaphthalen- 1- amineIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Semaphorin-3AIBA 12/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Sertraline (Zoloft)FDA LinkGeneric 01/2022
1	Insulin ReceptorIBA 01/2022
1	TabletsIBA 12/2021
1	MelatoninIBA 12/2021
1	Polymethyl Methacrylate (Sol)IBA 11/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021
1	EndocannabinoidsIBA 01/2021
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2021
1	imidazoleacetic acid (IMAC)IBA 07/2020

Therapy/Procedure

15	Therapeutics 05/2024 - 11/2004
12	Neurofeedback 01/2024 - 11/2011
12	Drug Therapy (Chemotherapy) 01/2021 - 09/2013
6	Combined Modality Therapy 08/2018 - 11/2004
4	Precision Medicine 01/2023 - 04/2013
3	Behavior Control 10/2020 - 06/2015
3	Psychology Biofeedback (Biofeedback) 03/2019 - 11/2011
2	Treatment Delay 01/2021 - 11/2019
2	Cognitive Training 01/2016 - 03/2013
2	Aftercare (After-Treatment) 07/2010 - 11/2009
1	Puberty Suppression 01/2024
1	Secondary Prevention 01/2023